Format

Send to

Choose Destination
J Transl Med. 2013 Jun 9;11:139. doi: 10.1186/1479-5876-11-139.

Intracavernous administration of bone marrow mononuclear cells: a new method of treating erectile dysfunction?

Author information

1
Institute for Molecular Medicine, Huntington Beach, CA, USA. Thomas.ichim@gmail.com

Abstract

While PDE5 inhibitors have revolutionized treatment of ED, approximately 30% of patients are non-responsive. A significant cause of this is vascular and smooth muscle dysfunction, as well as nerve atrophy. Autologous administration of bone marrow mononuclear cells (BMMC) has been performed in over 2000 cardiac patients without adverse effects, for stimulation of angiogenesis/regeneration. Despite its ease of access, and dependence on effective vasculature for function, comparatively little has been perform in terms of BMMC therapy for ED. Here we outline the rationale for use of autologous BMMC in patients with ED, as well as provide early safety data on the first use of this procedure clinically.

PMID:
23758954
PMCID:
PMC3718667
DOI:
10.1186/1479-5876-11-139
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center